Dr. Mary R. Rensel, MD

Dr. Rensel practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Rensel's NPI, 1083640197, was assigned on June 23, 2006. Dr. Rensel graduated from Medical College of Ohio in 1992. Dr. Rensel holds Ohio license 35068809.

Dr. Rensel's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Rensel's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Rensel to 2 more clinical labs, each named with a free account. Dr. Rensel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rensel practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Rensel's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Rensel is licensed in Ohio.

CMS data shows 112 Medicare services from Dr. Rensel across 3 procedure codes in 2024, for 104 Medicare patients. Medicare paid $6,988 for them.

CMS counts 104 Medicare patients who saw Dr. Rensel in 2024. The largest group is 65 to 74, with 58 patients. 65% of them have high cholesterol, and 62% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rensel's median patient age at 53, with 76% women.

In 2024, Dr. Rensel wrote 492 Medicare Part D claims for 104 patients. 66% of them were for generic drugs. CMS names the drug for 394 of them, across 14 drugs with 11 or more claims each, at $1,796,845 in total drug cost. In 2023, CMS named 471 claims across 14 drugs.

Dr. Rensel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rensel as offering telehealth.

Dmand AI links 62 papers to Dr. Rensel, published from 2017 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Multiple Sclerosis, Age of Onset and Disease Progression. Dr. Rensel has published most often in Mult Scler. Dr. Rensel's most frequent co-authors are Soe Soe Mar, MD, Tanuja Chitnis, MD and Lauren B. Krupp, MD.

Dmand AI links Dr. Rensel to 1 clinical trial. Conditions studied include Multiple Sclerosis, Relapsing-Remitting and Multiple Sclerosis.

CMS Open Payments shows 382 general payments to Dr. Rensel from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Sanofi and Genzyme US Companies paid the most, $103,499. It also lists 4 research payments totaling $8,838 from 2020 to 2024.

Dr. Rensel graduated from Medical College of Ohio in 1992.